Table 2.
Postindex prescription information (12 months)
| Prescribed antihyperglycemic medications | n (%) |
|---|---|
| Oral AHA | 193 (43.4) |
| Metformin | 147 (33.0) |
| Sulfonylurea | 46 (10.3) |
| DPP-4 | 17 (3.8) |
| TZD | 34 (7.6) |
| Other | 3 (0.7) |
| Non-insulin injectable AHA | 65 (14.6) |
| GLP-1 receptor agonists | 15 (3.4) |
| Pramlintide | 50 (11.2) |
| Unknown | 2 (0.5) |
| Insulin (group) | |
| U-500R only (group A) | 209 (47.0) |
| U-500R with overlapping U-100 (group B) | 236 (53.0) |
AHA, antihyperglycemic agents; DPP-4, dipeptidyl peptidase-4 inhibitor; GLP-1, glucagon-like peptide 1; n, number of patients; TZD, thiazolidinedione.